DOMH - Dominari Holdings Forward P/S Multiple

Dominari Holdings Inc. (DOMH) cash flows are unstable due to the specific nature of biotech and finance transactions. The future P/S metric visualizes this asset volatility, where 0.20 describes the current status of the metric. Prospects are linked to a focus on eco-technologies and a digital office, although the company generally maintains basic compliance with green standards through the autonomy of its subsidiaries.

Dominari Financial - DOMH Market Cap to Expected Sales Ratio (period 08/27/2023 - 11/13/2026)

Analytical breakdowns and data insights for company aikidopharma.com (DOMH)

- market price and analyst price targets:

Price Chart Dominari Holdings|DOMH - Price Target Chart

- market capitalization statistics:

Market Capitalization DOMH|DOMH - Business Value

- issuer book value statistics:

Book Value per Share Dominari Holdings|DOMH - Book Valuation of Business|Market Value to Book Value Ratio aikidopharma.com|DOMH - Total Business Assets

- company total debt and liquidity indicators:

- financial results and valuation multiples details:

DOMH - Net Financial Result|Expected Profit Dominari Holdings Inc.|DOMH - Price to Earnings Multiple|Forward P/E Multiple Dominari Holdings|DOMH - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DOMH|DOMH - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Dominari Holdings|DOMH - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months aikidopharma.com|DOMH - Earnings per share increase in current year|Earnings growth forecast for next year Dominari Holdings Inc.

- sales volume and revenue indicators:

DOMH - Company Sales Revenue|Company Projected Revenue Dominari Holdings|DOMH - Price to Sales|Price-to-Projected Revenue Ratio DOMH

Fundamental company valuation:DOMH (Dominari Securities)

Dominari Holdings Inc. (DOMH) accumulates capital in high-tech biopharmaceutical projects where business valuation depends directly on revenue scaling rates. By analyzing the forward P/S ratio, an investor compares the holding's current market value with expected sales volume, which allows for determining the asset's degree of overbought status or identifying undervaluation potential through the dynamics of this coefficient.

Competitor analysis

Price-to-Projected Revenue Ratio Icahn Enterprises IEP|Hannon Armstrong Capital - Price-to-Projected Revenue Ratio|Central Securities Corp. - Forward P/S Multiple|INVA (Innoviva Therapeutics) - Market Cap to Projected Revenue|CNNE: Forward P/S Multiple|ECPG - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio PRA Group|Market Cap to Projected Revenue BGH (Barings Global Fund)|Forward P/S Multiple ACTG|Neuberger Berman (NBH) - Projected Price to Revenue|Forward P/S Multiple GLO (Clough Global Opportunities)|JRS: Market Cap to Projected Revenue|HGLB - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Roma Green Finance|OFS Credit (OCCI) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple ArrowMark Financial, Corp.|EDF (Stone Harbor Emerging Markets Income Fund) - Forward P/S Multiple|gabelli.com (GNT) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Heritage Global (HGBL)|Rafael Holdings Inc - Market Cap to Projected Revenue|Forward P/S Multiple GRF (Eagle Capital Growth Fund, Inc.)|Forward P/S Multiple Altisource Asset Management Corp AAMC|MCVT - Price-to-Projected Revenue Ratio|Forward Price to Sales TTP (closedendfunds.tortoiseadvisors.com)